Aviva PLC Significantly Increases Stakes in Coca-Cola, Hilton, and Other Large-Cap Firms

For Hilton Worldwide, Aviva PLC bought 7,498 shares in the fourth quarter to bring its position to 360,253 shares, worth $103,483,000; the article also notes institutional ownership at 95.90% and cites analyst target hikes (e.g., Raymond James raised its Hilton price objective from $300 to $355 and Bank of America from $324 to $375, both with “outperform/overweight” stances).
For Shopify, Aviva increased its stake to 1,023,213 shares after purchasing an additional 55,439 shares (valued at $164,880,000), while the article also provides market context and ownership: institutional investors own 69.27% and the stock opened at $110.47 (with a 50-day moving average of $114.20 and 200-day moving average of $131.77).
For Merck & Co., Aviva’s stake totals 2,887,354 shares after adding 115,048 during the quarter, valued at $303,923,000; the article adds that Merck makes up 0.5% of Aviva PLC’s portfolio and is its 26th-largest holding, with institutional ownership at 76.07%.
The Merck coverage in the article includes specific sell-side moves beyond the general “at least one price target trimmed” point: Wells Fargo lowered its price target from $150 to $145 while keeping an “overweight” rating, and Barclays initiated coverage with a $140 price target and an “overweight” rating.
For Coca-Cola, Aviva’s fourth-quarter purchase totaled 215,612 shares, lifting its position to 4,085,276 shares valued at $285,602,000; the article further notes Coca-Cola’s next quarterly dividend timing: declared payment on Wednesday, July 1, with record shareholders listed as of Monday, June 15.
Aviva PLC added 215,612 shares of Coca-Cola in the fourth quarter of 2025, bringing its total position to 4,085,276 shares worth approximately $285.6 million, according to Watchlist News. The purchase lifts Aviva's Coca-Cola stake by about 5.6%, as the record date for Coca-Cola's next $0.53-per-share quarterly dividend approaches on June 15.
The Coca-Cola move is part of a broader pattern. Aviva also grew its positions in Merck, Shopify, Hilton Worldwide, and Caterpillar during the same quarter. The purchases point to a steady institutional bet on large, stable companies with reliable cash flows.
Aviva's Coca-Cola holding will generate roughly $2.17 million in dividend income from the July 1 payment alone, based on the $0.53-per-share payout and its 4,085,276-share position. Coca-Cola has raised its dividend for 63 consecutive years, according to DividendInvestor, making it a core holding for Aviva's pension and life insurance funds.
Aviva CEO Amanda Blanc said in March 2026 that the firm is "in a very strong position to deliver long-term growth, especially in wealth where we attracted record net inflows of almost £11 billion." Aviva reported a 25% increase in operating profit, hitting its 2026 financial targets a full year early.
Aviva added 115,048 Merck shares in Q4, pushing its total to 2,887,354 shares worth $303.9 million. Merck is now Aviva's 26th-largest holding, making up 0.5% of its portfolio, according to Ticker Report. Institutional investors own 76.07% of Merck's shares overall.
Sell-side analysts remain broadly bullish. Barclays started coverage of Merck with an "overweight" rating and a $140 price target. Wells Fargo kept its "overweight" stance but trimmed its target from $150 to $145, citing roughly $2.5 billion in revenue at risk as older drugs like Januvia lose patent protection. For Hilton, Raymond James raised its target from $300 to $355 and Bank of America lifted its target from $324 to $375, both with positive ratings, according to MarketBeat.
Aviva bought 55,439 Shopify shares in Q4, lifting its stake to 1,023,213 shares valued at $164.9 million — a 5.7% increase. Shopify opened at $110.47 on June 11, well below its 200-day moving average of $131.77 and its 50-day moving average of $114.20, according to Shopify Investor Relations.
Institutional investors own 69.27% of Shopify's shares. The gap between Shopify's current price and its moving averages suggests the stock is under technical pressure. Still, Aviva's decision to add shares points to a "buy the dip" view on the company's long-term growth in commerce and AI integration.
Beyond Coca-Cola, Merck, Shopify, and Hilton, Aviva also raised its Caterpillar stake by about 5.5% in Q4. Separately, it grew positions in NXP Semiconductors by 8.9%, Union Pacific by 5.4%, Amgen by 5.5%, and Applied Materials by 5.4%, according to Watchlist News. It sold 60,056 Colgate-Palmolive shares during the same period.
The pattern across all these trades is consistent. Aviva is adding to large, well-established companies with strong cash flows and dominant market positions. With 22 million UK customers depending on its pension and insurance products, the firm is building a portfolio designed for long-term stability rather than short-term gains.
Publishers
29
Articles
38
Reach
67